Aura Minerals Valuation

Is A531 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A531 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A531 (€11.7) is trading below our estimate of fair value (€59.68)

Significantly Below Fair Value: A531 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for A531?

Key metric: As A531 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for A531. This is calculated by dividing A531's market cap by their current revenue.
What is A531's PS Ratio?
PS Ratio1.7x
SalesUS$546.97m
Market CapUS$920.68m

Price to Sales Ratio vs Peers

How does A531's PS Ratio compare to its peers?

The above table shows the PS ratio for A531 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.4x
SZG Salzgitter
0.09x2.1%€932.5m
STO3 Sto SE KGaA
0.4x1.8%€730.0m
TKA thyssenkrupp
0.07x1.1%€2.4b
ACT AlzChem Group
1.1x7.5%€594.3m
A531 Aura Minerals
1.7x14.8%€1.3b

Price-To-Sales vs Peers: A531 is expensive based on its Price-To-Sales Ratio (1.7x) compared to the peer average (0.4x).


Price to Sales Ratio vs Industry

How does A531's PS Ratio compare vs other companies in the European Metals and Mining Industry?

35 CompaniesPrice / SalesEstimated GrowthMarket Cap
A531 1.7xIndustry Avg. 0.7xNo. of Companies35PS00.81.62.43.24+
35 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: A531 is expensive based on its Price-To-Sales Ratio (1.7x) compared to the European Metals and Mining industry average (0.7x).


Price to Sales Ratio vs Fair Ratio

What is A531's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A531 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.7x
Fair PS Ratio0.9x

Price-To-Sales vs Fair Ratio: A531 is expensive based on its Price-To-Sales Ratio (1.7x) compared to the estimated Fair Price-To-Sales Ratio (0.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A531 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€11.70
€9.73
-16.9%
35.3%€13.21€5.06n/a3
Nov ’25€11.50
€9.82
-14.6%
34.7%€13.30€5.19n/a3
Oct ’25€10.20
€8.73
-14.5%
41.7%€11.62€3.59n/a3
Sep ’25€8.15
€8.73
+7.1%
41.7%€11.62€3.59n/a3
Aug ’25€8.90
€10.77
+21.0%
10.8%€11.69€9.14n/a3
Jul ’25€7.35
€10.68
+45.3%
9.7%€11.83€9.32n/a3
Jun ’25€7.75
€9.82
+26.7%
11.3%€11.48€8.53n/a4
May ’25€6.65
€9.87
+48.4%
9.9%€11.27€8.66n/a4
Apr ’25€6.35
€9.13
+43.7%
6.9%€10.13€8.47n/a4
Mar ’25€5.50
€9.20
+67.3%
7.1%€10.23€8.51n/a4
Feb ’25€5.55
€10.23
+84.3%
14.5%€13.05€8.82n/a5
Jan ’25€5.95
€10.02
+68.5%
14.5%€12.85€8.76n/a5
Dec ’24€6.15
€9.85
+60.1%
13.9%€12.52€8.76n/a5
Nov ’24€5.90
€10.44
+77.0%
13.8%€13.16€9.10€11.505
Oct ’24€5.40
€10.35
+91.7%
11.2%€12.35€9.03€10.205
Sep ’24€5.50
€10.30
+87.3%
11.2%€12.30€8.97€8.155
Aug ’24€6.60
€10.45
+58.3%
14.5%€13.05€8.75€8.905
Jul ’24€5.75
€10.49
+82.4%
12.7%€12.37€8.65€7.355
Jun ’24€6.00
€10.35
+72.4%
12.6%€12.25€8.56€7.755
May ’24€6.70
€10.64
+58.8%
15.5%€12.18€7.53€6.655
Apr ’24€6.70
€10.47
+56.3%
16.0%€12.19€7.52€6.355
Mar ’24€6.85
€10.66
+55.6%
16.0%€12.40€7.65€5.505
Feb ’24€7.30
€11.05
+51.3%
21.9%€14.23€7.53€5.554
Jan ’24€4.96
€11.58
+133.4%
22.3%€15.07€7.92€5.954
Dec ’23€5.15
€11.73
+127.8%
22.2%€15.25€8.02€6.154
Nov ’23€7.20
€12.40
+72.2%
16.8%€15.41€9.73€5.904

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies